Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
316.40
+2.90 (0.93%)
Jul 7, 2026, 10:54 AM EDT - Market open
PRAX Market Cap
PRAX has a market cap or net worth of $8.82 billion as of July 7, 2026. Its market cap has increased by 907.80% in one year.
Market Cap
8.82B
Enterprise Value
7.29B
1-Year Change
907.80%
Ranking
Category
Stock Price
$316.40
Market Cap Chart
Since the IPO on October 16, 2020, PRAX's market cap has increased from $698.02M to $8.82B, an increase of 1,163.69%. That is a compound annual growth rate of 55.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 8.82B | 19.68% |
| Dec 31, 2025 | 7.37B | 397.55% |
| Dec 31, 2024 | 1.48B | 675.84% |
| Dec 29, 2023 | 190.94M | 70.27% |
| Dec 30, 2022 | 112.14M | -87.31% |
| Dec 31, 2021 | 883.49M | -58.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apogee Therapeutics | 9.96B |
| ImmunityBio | 9.89B |
| Nuvalent | 9.77B |
| Corcept Therapeutics | 9.68B |
| Halozyme Therapeutics | 9.42B |
| Kymera Therapeutics | 9.34B |
| Protagonist Therapeutics | 8.46B |
| Vaxcyte | 8.43B |